Cargando…

Mutation spectrum in a cohort with familial exudative vitreoretinopathy

PURPOSE: To expand the mutation spectrum of patients with familial exudative vitreoretinopathy (FEVR) disease. PARTICIPANTS: 74 probands (53 families and 21 sporadic probands) with familial exudative vitreoretinopathy (FEVR) disease and their available family members (n = 188) were recruited for seq...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Ning, Li, Wei, Han, Dong‐Ming, Gao, Jia‐Yu, Yang, Zheng‐Tao, Jiang, Li, Liu, Tian‐Bin, Chen, Yan‐Xian, Jiang, Xiao‐Sen, Zhou, Liang, Wu, Ji‐Hong, Huang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482396/
https://www.ncbi.nlm.nih.gov/pubmed/35876299
http://dx.doi.org/10.1002/mgg3.2021
_version_ 1784791445312372736
author Qu, Ning
Li, Wei
Han, Dong‐Ming
Gao, Jia‐Yu
Yang, Zheng‐Tao
Jiang, Li
Liu, Tian‐Bin
Chen, Yan‐Xian
Jiang, Xiao‐Sen
Zhou, Liang
Wu, Ji‐Hong
Huang, Xin
author_facet Qu, Ning
Li, Wei
Han, Dong‐Ming
Gao, Jia‐Yu
Yang, Zheng‐Tao
Jiang, Li
Liu, Tian‐Bin
Chen, Yan‐Xian
Jiang, Xiao‐Sen
Zhou, Liang
Wu, Ji‐Hong
Huang, Xin
author_sort Qu, Ning
collection PubMed
description PURPOSE: To expand the mutation spectrum of patients with familial exudative vitreoretinopathy (FEVR) disease. PARTICIPANTS: 74 probands (53 families and 21 sporadic probands) with familial exudative vitreoretinopathy (FEVR) disease and their available family members (n = 188) were recruited for sequencing. METHODS: Panel‐based targeted screening was performed on all subjects. Before sanger sequencing, variants of LRP5, NDP, FZD4, TSPAN12, ZNF408, KIF11, RCBTB1, JAG1, and CTNNA1 genes were verified by a series of bioinformatics tools and genotype–phenotype co‐segregation analysis. RESULTS: 40.54% (30/74) of the probands were sighted to possess at least one etiological mutation of the nine FEVR‐causative genes. The etiological mutation detection rate was 37.74% (20/53) in family‐attainable probands while 47.62% (10/21) in sporadic cases. The diagnosis rate of patients in the early‐onset subgroup (≤5 years old, 45.4%) is higher than that of the children or adolescence‐onset subgroup (6–16 years old, 42.1%) and the late‐onset subgroup (≥17 years old, 39.4%). A total of 36 etiological mutations were identified in this study, comprising 26 novel mutations and 10 reported mutations. LRP5 was the most prevalent mutant gene among the 36 mutation types with a percentage of 41.67% (15/36). Followed by FZD4 (10/36, 27.78%), TSPAN12 (5/36, 13.89%), NDP (4/36, 11.11%), KIF11 (1/36, 2.78%), and RCBTB1 (1/36, 2.78%). Among these mutations, 63.89% (23/36) were missense mutations, 25.00% (9/36) were frameshift mutations, 5.56% (2/36) were splicing mutations, 5.56% (2/36) were nonsense mutations. Moreover, the clinical pathogenicity of these variants was defined according to American College of Medical Genetics (ACMG) and genomics guidelines: 41.67% (15/36) were likely pathogenic variants, 27.78% (10/36) pathogenic variants, 30.55% (11/36) variants of uncertain significance. No etiological mutations discovered in the ZNF408, JAG1, and CTNNA1 genes in this FEVR cohort. CONCLUSIONS: We systematically screened nine FEVR disease‐associated genes in a cohort of 74 Chinese probands with FEVR disease. With a detection rate of 40.54%, 36 etiological mutations of six genes were authenticated in 30 probands, including 26 novel mutations and 10 reported mutations. The most prevalent mutated gene is LRP5, followed by FZD4, TSPAN12, NDP, KIF11, and RCBTB1. In total, a de novo mutation was confirmed. Our study significantly clarified the mutation spectrum of variants bounded up to FEVR disease.
format Online
Article
Text
id pubmed-9482396
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94823962022-09-28 Mutation spectrum in a cohort with familial exudative vitreoretinopathy Qu, Ning Li, Wei Han, Dong‐Ming Gao, Jia‐Yu Yang, Zheng‐Tao Jiang, Li Liu, Tian‐Bin Chen, Yan‐Xian Jiang, Xiao‐Sen Zhou, Liang Wu, Ji‐Hong Huang, Xin Mol Genet Genomic Med Original Articles PURPOSE: To expand the mutation spectrum of patients with familial exudative vitreoretinopathy (FEVR) disease. PARTICIPANTS: 74 probands (53 families and 21 sporadic probands) with familial exudative vitreoretinopathy (FEVR) disease and their available family members (n = 188) were recruited for sequencing. METHODS: Panel‐based targeted screening was performed on all subjects. Before sanger sequencing, variants of LRP5, NDP, FZD4, TSPAN12, ZNF408, KIF11, RCBTB1, JAG1, and CTNNA1 genes were verified by a series of bioinformatics tools and genotype–phenotype co‐segregation analysis. RESULTS: 40.54% (30/74) of the probands were sighted to possess at least one etiological mutation of the nine FEVR‐causative genes. The etiological mutation detection rate was 37.74% (20/53) in family‐attainable probands while 47.62% (10/21) in sporadic cases. The diagnosis rate of patients in the early‐onset subgroup (≤5 years old, 45.4%) is higher than that of the children or adolescence‐onset subgroup (6–16 years old, 42.1%) and the late‐onset subgroup (≥17 years old, 39.4%). A total of 36 etiological mutations were identified in this study, comprising 26 novel mutations and 10 reported mutations. LRP5 was the most prevalent mutant gene among the 36 mutation types with a percentage of 41.67% (15/36). Followed by FZD4 (10/36, 27.78%), TSPAN12 (5/36, 13.89%), NDP (4/36, 11.11%), KIF11 (1/36, 2.78%), and RCBTB1 (1/36, 2.78%). Among these mutations, 63.89% (23/36) were missense mutations, 25.00% (9/36) were frameshift mutations, 5.56% (2/36) were splicing mutations, 5.56% (2/36) were nonsense mutations. Moreover, the clinical pathogenicity of these variants was defined according to American College of Medical Genetics (ACMG) and genomics guidelines: 41.67% (15/36) were likely pathogenic variants, 27.78% (10/36) pathogenic variants, 30.55% (11/36) variants of uncertain significance. No etiological mutations discovered in the ZNF408, JAG1, and CTNNA1 genes in this FEVR cohort. CONCLUSIONS: We systematically screened nine FEVR disease‐associated genes in a cohort of 74 Chinese probands with FEVR disease. With a detection rate of 40.54%, 36 etiological mutations of six genes were authenticated in 30 probands, including 26 novel mutations and 10 reported mutations. The most prevalent mutated gene is LRP5, followed by FZD4, TSPAN12, NDP, KIF11, and RCBTB1. In total, a de novo mutation was confirmed. Our study significantly clarified the mutation spectrum of variants bounded up to FEVR disease. John Wiley and Sons Inc. 2022-07-25 /pmc/articles/PMC9482396/ /pubmed/35876299 http://dx.doi.org/10.1002/mgg3.2021 Text en © 2022 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Qu, Ning
Li, Wei
Han, Dong‐Ming
Gao, Jia‐Yu
Yang, Zheng‐Tao
Jiang, Li
Liu, Tian‐Bin
Chen, Yan‐Xian
Jiang, Xiao‐Sen
Zhou, Liang
Wu, Ji‐Hong
Huang, Xin
Mutation spectrum in a cohort with familial exudative vitreoretinopathy
title Mutation spectrum in a cohort with familial exudative vitreoretinopathy
title_full Mutation spectrum in a cohort with familial exudative vitreoretinopathy
title_fullStr Mutation spectrum in a cohort with familial exudative vitreoretinopathy
title_full_unstemmed Mutation spectrum in a cohort with familial exudative vitreoretinopathy
title_short Mutation spectrum in a cohort with familial exudative vitreoretinopathy
title_sort mutation spectrum in a cohort with familial exudative vitreoretinopathy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482396/
https://www.ncbi.nlm.nih.gov/pubmed/35876299
http://dx.doi.org/10.1002/mgg3.2021
work_keys_str_mv AT quning mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT liwei mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT handongming mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT gaojiayu mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT yangzhengtao mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT jiangli mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT liutianbin mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT chenyanxian mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT jiangxiaosen mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT zhouliang mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT wujihong mutationspectruminacohortwithfamilialexudativevitreoretinopathy
AT huangxin mutationspectruminacohortwithfamilialexudativevitreoretinopathy